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Abstract
More than 20% of the world’s biodiversity is located in Brazilian
forests and only a few plant extracts have been evaluated for potential
antibacterial activity. In the present study, 705 organic and aqueous
extracts of plants obtained from different Amazon Rain Forest and
Atlantic Forest plants were screened for antibacterial activity at 100
µg/ml, using a microdilution broth assay against Staphylococcus
aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Esche-
richia coli. One extract, VO581, was active against S. aureus (mini-
mum inhibitory concentration (MIC) = 140 µg/ml and minimal bacte-
ricidal concentration (MBC) = 160 µg/ml, organic extract obtained
from stems) and two extracts were active against E. faecalis, SM053
(MIC = 80 µg/ml and MBC = 90 µg/ml, organic extract obtained from
aerial parts), and MY841 (MIC = 30 µg/ml and MBC = 50 µg/ml,
organic extract obtained from stems). The most active fractions are
being fractionated to identify their active substances. Higher concen-
trations of other extracts are currently being evaluated against the
same microorganisms.
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Introduction
The Brazilian Amazon Rain Forest is
home to 17% of the biodiversity found within
the country (1). The Atlantic Forest contains
approximately 35% of the world’s Angios-
permae, and more than 8% of the Pterido-
phytae (2). In view of this wealth of species
and that the Atlantic Forest is one of the
world’s foci for conservation (3), this biomas
should be studied in terms of pharmacologi-
cal or biological activity.
Approximately 20% of the plants found
in the world have been submitted to pharma-
cological or biological test, and a substantial
number of new antibiotics introduced on the
market are obtained from natural or semisyn-
thetic resources. It has been reported that
between the years 1983 and 1994, of 93 new
antibacterial agents submitted to analysis by
the FDA six were natural products (teicopla-
nin, mupirocin, miokamycin, carumonam,
isepamicin, and RV-11), 45 were semisyn-
thetic products modeled on a natural product
lead, and 7 antivirals were synthetic com-
pounds based on natural product models (4).
The systematic screening of antibacterial
plant extracts represents a continuous effort
to find new compounds with the potential to
act against multi-resistant bacteria.
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The principal aim of the present study
was to screen organic and aqueous extracts
obtained from the Brazilian Amazon Rain
Forest and Atlantic Forest for antibacterial
activity against Staphylococcus aureus, En-
terococcus faecalis, Pseudomonas aerugi-
nosa, and Escherichia coli.
Material and Methods
Plant collection and extract preparation
All plants were collected with the autho-
rization of Instituto Brasileiro do Meio
Ambiente e dos Recursos Naturais Renová-
veis (IBAMA), permits No. 053/99 and 038/
99. Plants were identified by Dr. Alexandre
A. Oliveira, USP, Ribeirão Preto, SP, Brazil,
and vouchers are deposited at the Herbarium
UNIP (Universidade Paulista, São Paulo, SP,
Brazil).
Seven hundred and five organic and aque-
ous extracts were obtained from plants na-
tive to the Amazon Rain Forest and Atlantic
Forest. Plants were collected using a tradi-
tional (5) and chemosystematic (6) approach.
Plant parts were collected according to the
biomass availability of each individual or
population, which varied according to the
species and habitat of each one, i.e., trees,
herbaceous plants, lianas, epiphytes or
shrubs. Plant material was dried and ground
before being submitted to 24-h maceration
with methanol:dichloromethane (1:1) followed
by 24-h maceration with water, resulting in
two extracts from each plant material. Further
information on the technique can be found
elsewhere (7). The number of extracts of
each family tested is given in the current text.
Antimicrobial assay
Broth microdilution method was used to
screen the 705 plant extracts. The inoculum
was prepared at the concentration of 10-2
CFU/ml, starting from a 0.5 McFarland (or
108 CFU/ml) prepared from fresh colonies
of bacteria as described below (8).
S. aureus ATCC 29213 (Sau), E. coli
ATCC 25922 (Ecol), E. faecalis ATCC
29212 (Efae) and P. aeruginosa ATCC 27853
(Psa) were the bacterial strains tested. The
bacterial inoculum of each ATCC strain was
obtained from fresh colonies grown on
Müeller Hinton agar plates. Each strain was
inoculated into 5 ml of Müeller-Hinton broth
in order to obtain a concentration of 1.5 x 108
CFU/ml (0.5 MacFarland). The inoculum
was then diluted to 1.5 x 102 CFU/ml. One
hundred and ninety microliters of this sus-
pension was transferred to each microplate
well. Ten microliters of each extract solution
was added to the microplate wells and incu-
bated at 35ºC for 18 to 20 h. Extracts were
prepared to 20 times the desired test concen-
tration (2 mg/ml) in water or 50% DMSO
solution. Results were analyzed visually and
classified according to the following patterns:
+ = bacterium colonies deposited in the bot-
tom of the well, ++ = turbidity with bacterium
colonies being deposited, +++ = light turbid-
ity, and ++++ = total growth inhibition.
The extracts were screened at a concen-
tration of 100 µg/ml. Extracts that showed
inhibitory activity at this concentration were
submitted to a subculture of the broth media
in Müeller Hinton agar (Oxoid®, Basing-
stoke, Hampshire, England) in order to evalu-
ate bacterial growth (8).
Determination of minimal inhibitory
concentration and minimal bactericidal
concentration
Minimal inhibitory concentration (MIC)
and minimal bactericidal concentration
(MBC) were determined for the extracts that
showed total growth inhibition using the
protocol described above. Extract concen-
trations of 10 to 100 µg/ml in steps of 10 µg
were evaluated. The concentration at which
there was no visually detectable bacterial
growth was taken as the MIC, and the con-
centration at which there was no bacterial
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growth after inoculation in Müeller-Hinton
agar (Oxoid®) was taken as the MBC.
Results
Results were visually analyzed and bac-
terial growth inhibition was confirmed after
inoculation in Müeller-Hinton agar. Many
extracts showed some degree of inhibition of
bacterial growth at concentrations of 100
µg/ml, represented by “++”. The MIC and
MBC of these extracts are currently being
obtained. The families of the plants from
which the extracts were obtained, the total
number of extracts obtained for the current
family, and the number of extracts whose
antibacterial activities were classified as “++”
against the respective bacteria tested are re-
ported in Table 1.
Table 2 lists the seven extracts tested at
the concentration of 100 µg/ml and classi-
fied as “+++” against E. faecalis. Table 3
lists the three plant extracts that showed
antibacterial activity against S. aureus and
E. faecalis, and their respective MIC and
MBC.
Table 1. Antibacterial activity of extracts prepared from plants obtained in the Amazon Rain Forest and the Atlantic Forest.
Family No. of extracts No. of extracts Family No. of extracts No. of extracts
evaluated with ++ activity evaluated with ++ activity
Anacardiaceae 1 1 Sau; 1 Efae Melastomataceae 23 13 Sau; 8 Efae
Annonaceae 34 28 Sau; 5  Efae Meliaceae 9 5 Sau; 3 Efae
Apocynaceae 54 20 Sau; 6 Efae Memecilaceae 4 3 Sau; 2 Efae
Aquifoliaceae 3 3 Sau; 2 Efae Monimiaceae 1 1 Sau; 1 Efae
Balanophoraceae 1 1 Efae Moraceae 3 3 Sau;
Bignoniaceae 16 10 Sau; 1 Efae Myristicaceae 6 6 Sau; 2 Efae
Bombacaceae 2 2 Sau; 2 Efae Myrsinaceae 6 6 Sau; 3 Efae
Boraginaceae 5 4 Sau; 1 Psa Myrtaceae 17 17 Sau; 11 Efae
Burseraceae 10 6 Sau; 1 Efae Ochnaceae 3 2 Sau; 2 Efae
Capparidaceae 8 2 Sau Olacaceae 6 5 Sau; 3 Efae
Caryocaraceae 5 4 Sau; 3 Efae Orchidaceae 1 1 Sau
Chrysobalanaceae 15 12 Sau; 1 Efae Passifloraceae 1 1 Sau
Clusiaceae 43 34 Sau; 18 Efae; 1 Ecol Polygalaceae 1 1 Sau
Combretaceae 8 8 Sau; 5 Efae Polygonaceae 14 11 Sau; 5 Efae
Commelinaceae 1 1 Sau Proteaceae 2 2 Efae
Connaraceae 10 9 Sau; 4 Efae Rabdodendraceae 7 4 Sau; 2 Efae
Convolvulaceae 1 1 Sau Rhyzophoraceae 3 2 Sau; 2 Efae
Dilleniaceae 4 3 Sau; 2 Efae Rubiaceae 51 35 Sau; 10 Efae
Ebenaceae 5 4 Sau; 2 Efae Rutaceae 4 4 Sau; 2 Efae
Erythroxylaceae 2 1 Sau Sapindaceae 12 7 Sau; 5 Efae
Euphorbiaceae 33 21 Sau; 14 Efae Sapotaceae 4 4 Sau; 1 Efae
Flacourtiaceae 18 15 Sau; 6 Efae Simaroubaceae 9 6 Sau; 3 Efae
Gentianaceae 5 2 Sau Smilacaceae 5 4 Sau; 3 Efae; 1 Psa
Heliconiaceae 2 2 Sau; 1 Efae Solanaceae 2 2 Sau
Hippocrateaceae 6 5 Sau; 3 Efae Styracaceae 2 2 Sau; 1 Efae
Humiriaceae 2 2 Sau; 2 Efae Theaceae 6 2 Sau
Lacistemataceae 2 1 Sau; 1 Efae Teophrastraceae 1 1 Sau
Lauraceae 19 17 Sau; 6 Efae Trigoniaceae 3 1 Sau
Lecythidaceae 6 6 Sau; 2 Efae Trimeriaceae 1 1 Sau; 1 Efae
Leguminosae 119 95 Sau; 53 Efae Verbenaceae 1 1 Sau
Linaceae 2 2 Efae Violaceae 7 4 Sau; 4 Efae
Loranthaceae 5 5 Sau; 4 Efae Vochysiaceae 5 4 Sau; 5 Efae
Malpighiaceae 21 17 Sau; 11 Efae
Activity was measured by the microdilution broth assay at 100 µg/ml. “++“ indicates that the extracts caused turbidity without
culture flocks and that they will be evaluated at higher concentrations. Ecol = Escherichia coli ATCC 25922; Efae = Enterococ-
cus faecalis ATCC 29212; Psa = Pseudomonas aeruginosa ATCC 27853; Sau = Staphylococcus aureus ATCC 29213.
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Discussion
Plant extracts have been studied against
bacteria for years, but in a more intensified
way in the last three decades. During this
period, a lot of antimicrobial screening evalu-
ations have been published based on the
traditional use of Chinese, African, and Asian
plant drugs (9-15). During the late 1990’s, a
large number of manuscripts describing meth-
odologies of screening took part and resulted
in more than 30 articles representing anti-
bacterial extracts obtained from Asian and
African native plants, but only a few studies
relating antibacterial activity of Brazilian
plant extracts were found (16-21). Brazil is
home to more than 20% of the world’s biodi-
versity (1) and only a few species have been
submitted to any sort of large-scale biologi-
cal screening. We collected a substantial
amount of information about the antimicro-
bial activity of 705 Brazilian plant extracts
which have been collected randomly.
In order to establish the extract concen-
trations to be used during the screening, we
observed that extract concentrations span-
ning from 25 µg/ml (22) to 2 mg/ml (23) or
even 40 mg/ml (18) have been used. We
screened the crude extracts using a concen-
tration of 100 µg/ml (24). Such concentra-
tion is nowadays considered the proper con-
centration an antimicrobial extract should
present. The dilution test is a very precise
technique that permits us to work with such
a low concentration.
Only 3 of 705 extracts showed bacteri-
cidal activity: extract VO581 against S. au-
reus and MY841 and SM053 against E.
faecalis, with the subcultures showing no
germ growth at concentrations ≥160 µg/ml.
Several crude extracts apparently inhibited
bacterial growth but when the bacteria were
subcultured in agar there was growth, as
shown above. Among them, we are currently
determining the MIC and MBC for all 510
crude extracts (72%) that showed “++” re-
sults against S. aureus, for all the 240 crude
extracts (34%) that showed “++” results
against E. faecalis, for the 2 extracts (0.3%)
that showed “++” results against P. aerugi-
nosa, for the extract (0.14%) that showed the
same result against E. coli, and for all the 7
extracts that showed “+++” results against
E. faecalis.
Extract MY841 (MIC = 30 µg/ml; MBC
= 50 µg/ml), obtained from the stem of a
Table 2. Antibacterial activity against Enterococcus faecalis of extracts prepared from
plants obtained in the Amazon Rain Forest and the Atlantic Forest.
Family Number of extracts Number of extracts classified
evaluated as +++ against Enterococcus
faecalis ATCC 29212
Asteraceae 9 1
Connaraceae 10 1
Flacourtiaceae 18 1
Lauraceae 19 1
Melastomataceae 23 1
Myrsinaceae 6 1
Rabdodendraceae 7 1
Activity was measured by the microdilution broth assay at 100 µg/ml. “+++” indicates
that the extracts caused light turbidity and that they will be evaluated at higher
concentrations.
Table 3. Antimicrobial activity of plant extracts from the Amazon Rain Forest that showed strong activity, and their corresponding minimal
inhibitory and minimal bactericidal concentrations.
Family Number of extracts Extract classified as ++++a Extract classified as ++++a Minimal inhibitory Minimal bactericidal
evaluated against Enterococcus against Staphylococcus concentration concentration
faecalis ATCC 29212 aureus ATCC 29213 (µg/ml) (µg/ml)
Myrsinaceae 6 MY841 0 140 160
Smilacaceae 5 SM053 0 80 90
Vochysiaceae 5 0 VO581 30 50
aActivity was measured by the microdilution broth assay. “++++” indicates that the extracts caused total growth inhibition.
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Myrsinaceae plant, showed antibacterial ac-
tivity against E. faecalis, as also did extract
SM053 (MIC = 80 µg/ml; MBC = 90 µg/ml),
obtained from the aerial parts of a
Smilacaceae plant. Extract VO581 (MIC =
140 µg/ml; MBC = 160 µg/ml), obtained
from the stem of a Vochysiaceae plant,
showed activity against S. aureus. The three
active extracts are going to be bioguide frac-
tionated in order to identify their active sub-
stances as well as the remaining extracts,
whose MICs were ≤500 µg/ml. Vochysiaceae
species have been studied phytochemically
and biologically, and beta-sitosterol, betulinic
acid and sericic acid have been isolated from
their stem bark extracts (25). These sub-
stances have shown antibacterial activity
against S. aureus. Polysaccharides were also
isolated from the cell walls of 57 species of
this family (26). Myrsinaceae have been
found to contain saponins (27), terpenoids
(28), and benzoquinone derivatives (29,30),
whereas no phytochemical or biological ac-
tivity has been reported for Smilacaceae.
It is a matter of major national interest to
study the potential of Brazilian forests in
offering new lead antibacterial compounds
that can be further synthesized and have
their activity improved. Thus, we strongly
hope to contribute to the conservation and
protection of the biodiversity of our forests
and to the development of the Brazilian com-
munity as a whole.
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